SpectronRx
PrivateLast Round
Early Funding
Apr 2, 2026
Total Funding Raised
$85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SpectronRx is a radiopharmaceutical company that provides therapeutic and diagnostic isotope solutions as a contract development and manufacturing organization (CDMO).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpectronRx Comparables
Compare SpectronRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AtomVie Global Radiopharma Inc. | 91% | |
| Nucleus RadioPharma | 88% | |
| NorthStar Medical Radioisotopes, LLC | 86% |
SpectronRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 2, 2026 |
Key People
Founding team and executive leadership
SpectronRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 52% MoM.
- Apr 2, 2026
$85M raised in early funding round.
SpectronRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SpectronRx's valuation, stock price, and market status.
Is SpectronRx a public or private company?
SpectronRx is a private company.
What is the current stock price of SpectronRx?
SpectronRx is a private company with no public stock price. No recent secondary market data is available.
How much is SpectronRx worth (valuation)?
Valuation information for SpectronRx is not publicly available.
Can I buy SpectronRx stock?
SpectronRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SpectronRx's last funding round?
SpectronRx's most recent funding round was Early Funding on April 2, 2026.
Who are the main investors in SpectronRx?
Key investors in SpectronRx include OrbiMed.
Will SpectronRx IPO soon?
No public IPO plans have been announced for SpectronRx.
How can I track SpectronRx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SpectronRx's secondary market activity and sign up for updates.